shire.com
Shire Newsroom: Media, News & Press Releases
https://www.shire.com/newsroom
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Thursday, September 1, 2016. Filter by: All Press Releases. Sort By: Most Recent. Sort By: A to Z. Sort By: Z to A. Head of Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. For Marketed Product and Pipeline Inquiries. Communications and Public Affairs. For All International Inquiries.
investors.shire.com
Shire: E-communications
http://investors.shire.com/shareholder-information/e-communications.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Electronic and Printed Communications – Making Your Choice. To do this you must register free at http:/ www.shareview.co.uk. Shire's electronic communicat...
investors.shire.com
Shire: Financial Highlights
http://investors.shire.com/financial-highlights.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Non GAAP adjusted ROIC. Non GAAP cash generation. Non GAAP EBITDA margin. Non GAAP operating income. This is a Non GAAP financial measure. Learn more abou...
shire.com
About Shire: Business Development & Partnerships
https://www.shire.com/who-we-are/how-we-operate/partnerships
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. A CLEAR AND FOCUSED BUSINESS DEVELOPMENT STRATEGY. We are constantly seeking out new innovation opportunities through strategic partnerships, acquisitions and licenses. We strive to bolster our core therapeutic areas and expand into high-value adjacent therapeutic areas to create the most value for our patients, partners and Shire. WHY PARTNER WITH SHIRE? By following thi...
shire.com
Shire: Our Leadership
https://www.shire.com/who-we-are/leadership
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Effective leadership is integral to the execution of Shire's strategy and therefore to the fulfillment of its objectives. Our leaders drive the vision of transforming the lives of people whose health is impacted by rare and other specialist conditions through innovative treatments. Our leadership includes the Board of Directors and the Executive Committee. The site uses c...
shire.com
About Shire: Our Culture
https://www.shire.com/who-we-are/our-story/our-culture
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. We are committed to recruit, develop and retain top talent who take a responsible and ethical approach to all that we do and who want to make a difference in the lives of patients across the globe. Read the Responsibility Review. Learn more about our approach to Responsibility, 2015 achievements and goals for 2016. Sign Up for Email or SMS Alerts.
shire.com
Shire: Our Approach to Responsibility
https://www.shire.com/who-we-are/responsibility/our-approach
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Our Policies and Positions. Responsibility has always been embedded in our business – we have never separated it from our daily activities, decisions, and relationships. Meeting ever-changing stakeholder expectations and anticipating emerging risks, issues, and opportunities continues to be integral to our approach to operating an ethical and responsible business. Our pri...
investors.shire.com
Shire: Annual and Interim Reports 2015
http://investors.shire.com/annual-and-interim-reports/year-2015.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Annual and Interim Reports. Aug 05, 2016. Jul 30, 2015. Mar 26, 2015. Annual Report for the year ended December 31, 2014.
shire.com
Contact Shire - Shire.com
https://www.shire.com/shireplc/en/contactus
Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Lexington, MA 02421. Tel: 1 617 349 0200. Tel: 41 0 41 288 40 00. Fax: 41 0 41 288 40 01. Hampshire International Business Park. Head of Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. Communications and Public Affairs. For Marketed Product and Pipeline Inquiries. Communications and Public Affairs. Shire Australia P...
investors.shire.com
Shire: Our Strategy
http://investors.shire.com/our-strategy.aspx
Skip to main content. Annual and Interim Reports. Annual and Interim Reports. Excellence in ADHD Patient Group Awards 2016. RESEARCH AND EDUCATIONAL GRANTS. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. Annual and Interim Reports. Shire proposed combination with Baxalta. Research and Development day. We drive performance from our currently marketed products to optimize revenue growth and cash generation. Prepare for approval and launch of lifitegrast (...
